Akebia Therapeutics Inc. (AKBA) announced after the bell Tuesday that it has agreed to expanded its collaboration for vadadustat with Otsuka Pharmaceutical Co. by entering into a collaboration and license agreement for Europe, China and other territories.
from RTT - Before the Bell http://ift.tt/2q9KB2y
via IFTTT
No comments:
Post a Comment